Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry S Coller

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
Journal of Clinical and Translational Science|June 30, 2021
Re-engineering The Clinical Research Enterprise in Response to COVID-19: The Clinical Translational Science Award (CTSA) experience and proposed playbook for future pandemicsBarry S Coller, John B Buse, Robert P Kimberly, et al.
Blood|November 25, 2003
Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytesAslihan Turhan, Pegah Jenab, Pierre Bruhns, et al.
Thrombosis and Haemostasis|September 28, 2002
Two new beta3 integrin mutations in Indian patients with Glanzmann thrombasthenia: localization of mutations affecting cysteine residues in integrin beta3Sona Nair, Jihong Li, W Beau Mitchell, et al.
Blood|June 12, 2008
In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1Jasimuddin Ahamed, Nathalie Burg, Keiji Yoshinaga, et al.
Blood|January 9, 2007
Mapping early conformational changes in alphaIIb and beta3 during biogenesis reveals a potential mechanism for alphaIIbbeta3 adopting its bent conformationW Beau Mitchell, Jihong Li, Marta Murcia, et al.
Clinical and Translational Science|December 21, 2012
Development of a research participants' perception survey to improve clinical researchJennifer L Yessis, Rhonda G Kost, Laura M Lee, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Mechanistic Basis for the Selective Recognition of the Fcγ Receptor IIa by Monoclonal Antibody IV.3Jialing Wang, Sabina Novack, Jihong Li, et al.
Thrombosis and Haemostasis|December 8, 2007
Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3Ronit Mor-Cohen, Nurit Rosenberg, Hava Peretz, et al.
Journal of Clinical and Translational Science|September 24, 2019
Preclinical Studies of RUC-4, a Novel Platelet αIIbβ3 Antagonist, in Non-Human Primates and With Human PlateletsSpandana Vootukuri, Jihong Li, Mark Nedelman, et al.
Circulation|May 21, 2003
Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic strokeLi Zhang, Zheng Gang Zhang, Ruilan Zhang, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Journal of Clinical and Translational Science|June 30, 2021
Re-engineering The Clinical Research Enterprise in Response to COVID-19: The Clinical Translational Science Award (CTSA) experience and proposed playbook for future pandemicsBarry S Coller, John B Buse, Robert P Kimberly, et al.
Blood|November 25, 2003
Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytesAslihan Turhan, Pegah Jenab, Pierre Bruhns, et al.
Thrombosis and Haemostasis|September 28, 2002
Two new beta3 integrin mutations in Indian patients with Glanzmann thrombasthenia: localization of mutations affecting cysteine residues in integrin beta3Sona Nair, Jihong Li, W Beau Mitchell, et al.
Blood|June 12, 2008
In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1Jasimuddin Ahamed, Nathalie Burg, Keiji Yoshinaga, et al.
Blood|January 9, 2007
Mapping early conformational changes in alphaIIb and beta3 during biogenesis reveals a potential mechanism for alphaIIbbeta3 adopting its bent conformationW Beau Mitchell, Jihong Li, Marta Murcia, et al.
Clinical and Translational Science|December 21, 2012
Development of a research participants' perception survey to improve clinical researchJennifer L Yessis, Rhonda G Kost, Laura M Lee, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Mechanistic Basis for the Selective Recognition of the Fcγ Receptor IIa by Monoclonal Antibody IV.3Jialing Wang, Sabina Novack, Jihong Li, et al.
Thrombosis and Haemostasis|December 8, 2007
Disulfide bond disruption by a beta 3-Cys549Arg mutation in six Jordanian families with Glanzmann thrombasthenia causes diminished production of constitutively active alpha IIb beta 3Ronit Mor-Cohen, Nurit Rosenberg, Hava Peretz, et al.
Journal of Clinical and Translational Science|September 24, 2019
Preclinical Studies of RUC-4, a Novel Platelet αIIbβ3 Antagonist, in Non-Human Primates and With Human PlateletsSpandana Vootukuri, Jihong Li, Mark Nedelman, et al.
Circulation|May 21, 2003
Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic strokeLi Zhang, Zheng Gang Zhang, Ruilan Zhang, et al.
Pageof 12